Sichuan Hebang Biotechnology Co Ltd (603077) — Capital Reinvestment Ratio
Sichuan Hebang Biotechnology Co Ltd (603077) has a Capital Reinvestment Ratio of 1.21x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥165.40 Million) in capital expenditures (CN¥200.76 Million). Check tangible net worth ratio of Sichuan Hebang Biotechnology Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sichuan Hebang Biotechnology Co Ltd Capital Reinvestment Ratio (2009–2025)
This chart tracks Sichuan Hebang Biotechnology Co Ltd's Capital Reinvestment Ratio across 16 annual periods. For the full cash flow conversion analysis, see Sichuan Hebang Biotechnology Co Ltd (603077) cash flow conversion.
Annual Capital Reinvestment Ratio for Sichuan Hebang Biotechnology Co Ltd (2009–2025)
Year-by-year Capital Reinvestment Ratio for Sichuan Hebang Biotechnology Co Ltd from 2009 to 2025. See Sichuan Hebang Biotechnology Co Ltd (603077) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.17x | CN¥1.08 Billion | CN¥1.26 Billion | ▼ -51.0% |
| 2024 | 2.39x | CN¥467.93 Million | CN¥1.12 Billion | ▼ -42.2% |
| 2023 | 4.13x | CN¥200.76 Million | CN¥828.74 Million | ▲ +1066.0% |
| 2022 | 0.35x | CN¥2.64 Billion | CN¥936.18 Million | ▼ -34.8% |
| 2021 | 0.54x | CN¥3.20 Billion | CN¥1.74 Billion | ▲ +1.6% |
| 2020 | 0.53x | CN¥368.85 Million | CN¥197.09 Million | ▼ -86.9% |
| 2019 | 4.07x | CN¥162.92 Million | CN¥662.54 Million | ▲ +956.4% |
| 2018 | 0.38x | CN¥944.39 Million | CN¥363.57 Million | ▼ -86.6% |
| 2017 | 2.87x | CN¥176.94 Million | CN¥508.53 Million | ▲ +144.0% |
| 2016 | 1.18x | CN¥575.26 Million | CN¥677.45 Million | ▼ -53.2% |
| 2015 | 2.52x | CN¥449.20 Million | CN¥1.13 Billion | ▼ -28.1% |
| 2014 | 3.50x | CN¥204.67 Million | CN¥716.77 Million | ▲ +72.6% |
| 2012 | 2.03x | CN¥134.96 Million | CN¥273.83 Million | ▲ +224.8% |
| 2011 | 0.62x | CN¥552.56 Million | CN¥345.17 Million | ▼ -63.8% |
| 2010 | 1.73x | CN¥330.77 Million | CN¥571.00 Million | ▼ -86.0% |
| 2009 | 12.30x | CN¥68.97 Million | CN¥848.53 Million | — |